Skip to search formSkip to main contentSkip to account menu

CA125 II Assay

Known as: CA125 II, CA125-II, CA125-II Assay 
A second generation radioimmunoassay to measure serum levels of CA-125.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Carbohydrate antigen 125 for mortality risk prediction following acute myocardial infarction
Carbohydrate antigen 125 (CA125) is a congestion and inflammation biomarker and has been proved to be related to a worse… 
2019
2019
CA125 over‐release behavior following a 75‐g oral glucose test as a predictive biomarker of multidrug resistance in patients with ovarian cancer
Multidrug resistance is a major cause of death in patients with ovarian cancer. To improve patient survival, we developed a novel… 
2013
2013
Ovarian malignancy risk strati fi cation of the adnexal mass using a multivariate index assay ☆
► The multivariate index assay (MVA) was evaluated in an intended-use population of non-gynecologic oncology practices. ► The MVA… 
2009
2009
TSGF CA125 CEA联合检测在卵巢癌诊断中的应用
卵巢癌是发生于卵巢组织的恶性肿瘤。卵巢癌有起病隐匿，早期不易发现，易转移，预后差等特点。占所有妇科恶性肿瘤的15… 
2003
2003
Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays
Background: In this study the clinical and technical performance of the CA125- detecting Bayer ACS:OV immunoluminometric serum… 
1997
1997
Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value.
The Byk LIA-mat CA125 II assay was compared with the Centocor IRMA CA125 II. Serum samples studied (n = 1012) were obtained from… 
Review
1996
Review
1996
Use of a second-generation CA125 assay in gynecologic patients.
OBJECTIVE To determine the correlation between the widely used CA125 assay and a second-generation assay, CA125 II, in a large… 
1995
1995
Clinical value of a new serum tumor marker, CA125II, in gynecologic disease: comparison with CA125.
CA125 II, an improved version of the conventional CA125 was compared with CA125 as to which was more useful in gynecologic… 
1993
1993
Clinical evaluation of new cancer-associated antigen CA125 II in epithelial ovarian cancers: comparison with CA125.
1993
1993
[Basic studies of BALL ELSA CA125-II KIT for detection of serum cancer antigen 125].
We made basic studies of BALL ELSA CA125-II KIT which is a solid phase two site immunoradiometric assay. The first monoclonal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)